Integrating HIV Prevention With TB Household Contact Evaluation in Uganda
NCT ID: NCT07119359
Last Updated: 2025-08-13
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
NA
2480 participants
INTERVENTIONAL
2025-09-30
2029-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Interrupting HIV and TB Stigma in the Household in Uganda
NCT05124665
A Pilot Study of Pre-Exposure Prophylaxis (PrEP) to Evaluate Safety, Acceptability, and Adherence in At-risk Populations in Uganda, Africa
NCT00931346
HIV PrEP Priming of Immune Effectors
NCT02593409
Peer-led Implementation of TB-HIV Education and Adherence Counseling in Uganda
NCT05917210
Implementing Oral (Event-driven and Daily) and Long-acting Pre-Exposure Prophylaxis in Mobile Men in Sub-Saharan Africa
NCT06133686
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Home-based HIV self-testing and PrEP initiation
Home-based HIV self-testing and PrEP initiation (for eligible participants) integrated into routine TB household contact investigation
Home-based HIV self-testing
Integration of HIV self-testing into TB household contact investigation
Home-based initiation of PrEP
Integration of PrEP initation into TB household contact investigation
Modified standard of care
Referral to health facility for HIV testing and PrEP initiation
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Home-based HIV self-testing
Integration of HIV self-testing into TB household contact investigation
Home-based initiation of PrEP
Integration of PrEP initation into TB household contact investigation
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Household includes ≥2 persons
* Age 15 years and older
* Willingness to participate in study procedures
Exclusion Criteria
* Lives outside the study area
* Any other condition that, in the opinion of the Investigator/designee, could preclude informed consent, make study participation unsafe, or otherwise interfere with achieving study objectives
15 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Infectious Diseases Institute, Uganda
OTHER
National Institute of Mental Health (NIMH)
NIH
University of Washington
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Jennifer Ross
Assistant Professor, Department of Medicine, Division of Allergy and Infectious Diseases
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jennifer M Ross, MD, MPH
Role: PRINCIPAL_INVESTIGATOR
University of Washington
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Infectious Diseases Institute
Kampala, , Uganda
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
STUDY00020907
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.